NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

enVVeno Medical Corporation (NASDAQ: NVNOW)

 
NVNOW Technical Analysis
5
As on 24th Jan 2022 NVNOW Share Price closed @ 0.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NVNOW Share Price

Open 0.25 Change Price %
High 0.25 1 Day -0.05 -18.52
Low 0.22 1 Week -0.11 -33.33
Close 0.22 1 Month -0.13 -37.14
Volume 5100 1 Year -0.20 -47.62
52 Week High 0.50 | 52 Week Low 0.19
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
NVNOW
Daily Charts
NVNOW
Intraday Charts
Whats New @
Bazaartrend
NVNOW
Free Analysis
 
NVNOW Important Levels Intraday
RESISTANCE0.28
RESISTANCE0.26
RESISTANCE0.25
RESISTANCE0.24
SUPPORT0.20
SUPPORT0.19
SUPPORT0.18
SUPPORT0.16
 
NVNOW Target for Month January
4th UP TARGET0.62
3rd UP TARGET0.49
2nd UP TARGET0.41
1st UP TARGET0.33
1st DOWN TARGET0.11
2nd DOWN TARGET0.03
3rd DOWN TARGET-0.05
4th DOWN TARGET-0.18
 
NVNOW Weekly Target
4th UP TARGET0.30
3rd UP TARGET0.27
2nd UP TARGET0.26
1st UP TARGET0.24
1st DOWN TARGET0.20
2nd DOWN TARGET0.18
3rd DOWN TARGET0.17
4th DOWN TARGET0.14
 
NVNOW Target for Year 2022
4th UP TARGET0.89
3rd UP TARGET0.68
2nd UP TARGET0.54
1st UP TARGET0.41
1st DOWN TARGET0.03
2nd DOWN TARGET-0.1
3rd DOWN TARGET-0.24
4th DOWN TARGET-0.45
 
 
NVNOW Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
NVNOW Address
NVNOW
 
NVNOW Latest News
 
Your Comments and Response on enVVeno Medical Corporation
 
NVNOW Business Profile
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based devices to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and works as a replacement venous valve to reduce reflux and venous hypertension, as well as to restore proper directional blood flow back to the heart. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Address:
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service